Issues & Trends

Laseroptek Co., Ltd.: “Set for a Comeback Through Strengthening Our Disease Treatment Portfolio and Normalizing Operations in North America”

26th Anniversary… "Earnings Rebound to Begin in Earnest This Year"

Kwon Oh Seok
2026-07-27 08:46:11
[Edaily Reporter Kwon Oh Seok ] Laseroptek Co., Ltd.(199550), a company specializing in laser devices for skin care and the treatment of skin conditions, announced on the 27th that it held a commemorative ceremony at its headquarters in Seongnam, Gyeonggi Province, to mark its 26th anniversary.
(Photo courtesy of Laseroptek Co., Ltd.)

Founded in 2000, Laseroptek Co., Ltd. has accumulated technological expertise in the treatment of pigmentation, vascular conditions, and other skin disorders since becoming the first company in Korea to independently develop medical lasers. Following the launch of products such as “PALLAS,” “PicoLO,” and “Helios 785 Pico,” the company entered the consumables market last year with the release of “SCULPIO,” and this year unveiled the “VASCURA 589,” a high-power, solid-state 589nm vascular laser.
The company plans to use this commemorative event as an opportunity to accelerate the normalization of its North American operations and the expansion of its therapeutic laser portfolio. In particular, the company’s strategy is to strengthen its penetration of the global vascular laser market, centered on the “VASCURA 589,” and to expand its revenue structure—currently focused on aesthetics—into the therapeutic sector, aiming to improve the ratio of aesthetics to therapy to approximately 7:3 over the medium to long term.
It has also completed the reorganization of its North American sales network. The company has established a direct sales system centered on the U.S. West Coast and Texas and has expanded its market into Canada. The company expects a rebound in performance starting in the second half of this year, followed by full-scale growth beginning in the first quarter of 2027, once the U.S. litigation issues are resolved.
Chairman Joo Hong stated, “Strengthening our fundamentals and solidifying our foundation is key to future growth,” while CEO Lee Chang-jin said, “We will expand our business scope to focus on disease treatment and actively target the global market.” The event also included an awards ceremony honoring long-serving employees and outstanding staff members.

Economy

Corporation

IT·Science

Economy

“Special Oversight? What Haven’t Gone Up?”… Gradual Price Hikes on Ramen and Pizza, Some Items Up 67%

Although the government has launched special measures to curb consumer prices, data shows that prices for about six out of ten items under scrutiny have risen over the past seven months.Prices for fab…
2026-10-26 04:50:03

Corporation

“Wasn’t Moderna the one that provided the cancer vaccine?”…Domestic treatment to prevent cancer recurrence

A “cancer vaccine” craze is sweeping the global anticancer drug market. This follows Moderna’s demonstration that its personalized mRNA cancer vaccine has the potential to suppress cancer recurrence. …
2026-10-26 06:01:02

IT·Science

As AI Lowers the Barrier to Coding, 'Local Developer Groups' Surge… New Sign-ups on Karrot Up 931%

An app that delivers messages at the speed of a flying pigeon; a website that shows what South Korea looked like at the time of your birth when you enter your date of birth. These are some of the uniq…
2026-10-26 04:05:03